Provide healthcare staff with personality-driven insights for customizing patient interaction, which improves patient experiences. Deliver more effective intervention plans and instructions by adjusting style of speech or amount of detail to patient preferences, to enable better recall and understanding of medical information.
This creates a positive rapport which motivates patients to become partners in their treatment and stay the course for the long run. It enables close accompaniment of patients, aimed at achieving a better outcome of therapy and preventing diseases.
Identify specific hidden emotional non-adherence barriers of chronic patients with CVD, heart disease, diabetes, etc., and tailor guidelines to overcome these barriers.
Empower patients to cope with their disease and better self-manage their health by following dietary and exercise fitness regimens.
Pinpoint sub-threshold signs of depression, e.g., following a heart attack, or cognitive changes caused by medication, which could enable you to start early treatment.
Deepen your understanding of each patient’s character beyond information in the medical record, and utilize technologies intended for continuous remote patient monitoring, and improving mental states, following treatment. Define specific indicators to be flagged and receive real-time alerts about possible risk.
Provide personality-driven empathic guidance using health and wellness digital assistants which can increase adherence, prevent worsening or relapse of symptoms, and detect symptom improvement.
By shifting patient interactions to other healthcare staff and to digital assistants you reduce the number of doctor visits, ease physician’s workload, and minimize time spent in waiting rooms.
Extend the reach of healthcare personnel and move towards improving care for larger and remote populations.
Launch a shift that assists in optimizing treatment by administrating it at the exact time that can improve post-surgery and chronic care management.
Move towards lowering nonadherence-related mortality and comorbidity rates and cut treatment and rehospitalization costs.
Reduce the costs of trial and error of medications and treatment, and the risk of adverse drug reactions.